Brief: IPCA Laboratories Says US FDA Conducted Inspection Of Co's Formulations Manufacturing Facility Situated At Pithampur
23/06/2023 13:51
June 23 (Reuters) - IPCA Laboratories Ltd IPCA.NS :
* US FDA CONDUCTED INSPECTION OF CO'S FORMULATIONS
MANUFACTURING
FACILITY SITUATED AT PITHAMPUR
* AT CLOSE OF INSPECTION US FDA ISSUED FORM 483 WITH 8
OBSERVATIONS
Source text for Eikon: ID:nBSE26c06
Further company coverage: IPCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ipca Laboratories
See all newsBrief: Ipca Labs March-Quarter Consol Net Profit 3 Billion Rupees
Brief: Ipca Labs Posts Dec-Qtr Consol Net PAT 3.26 Billion Rupees
Brief: IPCA Labs Says US FDA Issues Form 483 With Three Observations
Brief: IPCA Labs Sept-Quarter Consol Net Pat 2.83 Billion Rupees
Brief: IPCA Labs Says To Sell Unit In Ankleshwar For 221.5 Mln Rupees